Heart Failure Certification (HF-C) Practice Exam
50 Questions with Verified Answers and Detailed
Rationales
Based on ACC/AHA/HFSA Guidelines and HF-
Cert Exam Blueprint
Instructions
This practice exam is designed to simulate the Heart Failure Certification
(HF-Cert) examination administered by the Heart Failure Society of America
(HFSA). The exam consists of 50 multiple-choice questions covering the four
content domains of the HF-Cert blueprint -11. Each question includes the correct
answer and a detailed rationale to reinforce clinical reasoning.
Domain I: Assessment and Diagnosis
, Question 1
A 47-year-old Black woman presents for a cardiology follow-up 6 weeks after an acute inferior
myocardial infarction and PCI of the RCA. Her LVEF during hospitalization was 42%. Current medications
include aspirin, ticagrelor, rosuvastatin, metoprolol succinate 25 mg daily, lisinopril 10 mg daily, and
metformin. She reports no dyspnea, orthopnea, or fatigue. Current echocardiogram reveals LVEF 45%.
Which stage of heart failure best describes this patient?
A. Stage A (At risk for HF)
B. Stage B (Pre-HF)
C. Stage C (Symptomatic HF)
D. Stage D (Advanced HF)
Answer: B. Stage B (Pre-HF)
Rationale: This patient has structural heart disease (SHD), demonstrated by LVEF <50% post-MI,
but does not have current or previous symptoms of heart failure. Stage B describes patients with SHD
but no HF symptoms. Stage A includes patients at risk without SHD or symptoms. Stage C requires SHD
with current or previous symptoms. Stage D describes refractory symptoms despite optimal therapy -1-
5.
Question 2
A patient presents with dyspnea on exertion, orthopnea, and paroxysmal nocturnal dyspnea. These
symptoms are most characteristic of:
A. Right-sided heart failure
B. Left-sided heart failure
, C. High-output heart failure
D. Constrictive pericarditis
Answer: B. Left-sided heart failure
Rationale: Left-sided heart failure leads to pulmonary congestion, causing dyspnea on exertion,
orthopnea (dyspnea when lying flat), and paroxysmal nocturnal dyspnea (sudden awakening with
shortness of breath) due to fluid backing up into the lungs. Right-sided heart failure causes systemic
venous congestion leading to peripheral edema, JVD, and hepatomegaly -3-6.
Question 3
Which biomarker is most useful for diagnosing and prognosticating heart failure?
A. Troponin I
B. CK-MB
C. B-type natriuretic peptide (BNP)
D. C-reactive protein
Answer: C. B-type natriuretic peptide (BNP)
Rationale: BNP and NT-proBNP levels correlate with ventricular wall stress and volume
overload, making them the primary biomarkers for diagnosing heart failure, assessing severity, and
determining prognosis. Troponin indicates myocardial injury, CK-MB is specific to myocardial infarction,
and CRP is a non-specific inflammatory marker -3-6.
, Question 4
Which of the following is the most common cause of heart failure in developed countries?
A. Hypertension
B. Coronary artery disease
C. Valvular heart disease
D. Viral myocarditis
Answer: B. Coronary artery disease
Rationale: Coronary artery disease (CAD) is the leading cause of heart failure in developed
countries due to ischemic injury to the myocardium, which impairs cardiac function. Hypertension is a
major risk factor but typically acts through CAD or left ventricular hypertrophy. Valvular disease and
myocarditis are less common causes -3-6.
Question 5
Which electrolyte abnormality is commonly associated with loop diuretic therapy in heart failure?
A. Hyperkalemia
B. Hypermagnesemia
C. Hypokalemia
D. Hypercalcemia
Answer: C. Hypokalemia
Rationale: Loop diuretics (e.g., furosemide) increase renal excretion of potassium, leading to
hypokalemia, which increases the risk of arrhythmias, especially in patients also on digoxin. Monitoring
50 Questions with Verified Answers and Detailed
Rationales
Based on ACC/AHA/HFSA Guidelines and HF-
Cert Exam Blueprint
Instructions
This practice exam is designed to simulate the Heart Failure Certification
(HF-Cert) examination administered by the Heart Failure Society of America
(HFSA). The exam consists of 50 multiple-choice questions covering the four
content domains of the HF-Cert blueprint -11. Each question includes the correct
answer and a detailed rationale to reinforce clinical reasoning.
Domain I: Assessment and Diagnosis
, Question 1
A 47-year-old Black woman presents for a cardiology follow-up 6 weeks after an acute inferior
myocardial infarction and PCI of the RCA. Her LVEF during hospitalization was 42%. Current medications
include aspirin, ticagrelor, rosuvastatin, metoprolol succinate 25 mg daily, lisinopril 10 mg daily, and
metformin. She reports no dyspnea, orthopnea, or fatigue. Current echocardiogram reveals LVEF 45%.
Which stage of heart failure best describes this patient?
A. Stage A (At risk for HF)
B. Stage B (Pre-HF)
C. Stage C (Symptomatic HF)
D. Stage D (Advanced HF)
Answer: B. Stage B (Pre-HF)
Rationale: This patient has structural heart disease (SHD), demonstrated by LVEF <50% post-MI,
but does not have current or previous symptoms of heart failure. Stage B describes patients with SHD
but no HF symptoms. Stage A includes patients at risk without SHD or symptoms. Stage C requires SHD
with current or previous symptoms. Stage D describes refractory symptoms despite optimal therapy -1-
5.
Question 2
A patient presents with dyspnea on exertion, orthopnea, and paroxysmal nocturnal dyspnea. These
symptoms are most characteristic of:
A. Right-sided heart failure
B. Left-sided heart failure
, C. High-output heart failure
D. Constrictive pericarditis
Answer: B. Left-sided heart failure
Rationale: Left-sided heart failure leads to pulmonary congestion, causing dyspnea on exertion,
orthopnea (dyspnea when lying flat), and paroxysmal nocturnal dyspnea (sudden awakening with
shortness of breath) due to fluid backing up into the lungs. Right-sided heart failure causes systemic
venous congestion leading to peripheral edema, JVD, and hepatomegaly -3-6.
Question 3
Which biomarker is most useful for diagnosing and prognosticating heart failure?
A. Troponin I
B. CK-MB
C. B-type natriuretic peptide (BNP)
D. C-reactive protein
Answer: C. B-type natriuretic peptide (BNP)
Rationale: BNP and NT-proBNP levels correlate with ventricular wall stress and volume
overload, making them the primary biomarkers for diagnosing heart failure, assessing severity, and
determining prognosis. Troponin indicates myocardial injury, CK-MB is specific to myocardial infarction,
and CRP is a non-specific inflammatory marker -3-6.
, Question 4
Which of the following is the most common cause of heart failure in developed countries?
A. Hypertension
B. Coronary artery disease
C. Valvular heart disease
D. Viral myocarditis
Answer: B. Coronary artery disease
Rationale: Coronary artery disease (CAD) is the leading cause of heart failure in developed
countries due to ischemic injury to the myocardium, which impairs cardiac function. Hypertension is a
major risk factor but typically acts through CAD or left ventricular hypertrophy. Valvular disease and
myocarditis are less common causes -3-6.
Question 5
Which electrolyte abnormality is commonly associated with loop diuretic therapy in heart failure?
A. Hyperkalemia
B. Hypermagnesemia
C. Hypokalemia
D. Hypercalcemia
Answer: C. Hypokalemia
Rationale: Loop diuretics (e.g., furosemide) increase renal excretion of potassium, leading to
hypokalemia, which increases the risk of arrhythmias, especially in patients also on digoxin. Monitoring
